SES vs. ENTA
SES (SES AI Corp) and ENTA (Enanta Pharmaceuticals, Inc.) are both stocks. SES operates in Auto Parts (Consumer Cyclical), while ENTA operates in Biotechnology (Healthcare). Over the past 5 years, SES returned -35.53%/yr vs -25.36%/yr for ENTA. At a 0.16 correlation, their price movements are largely independent.
Performance
SES vs. ENTA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SES achieves a -37.78% return, which is significantly lower than ENTA's -29.80% return.
SES
- 1D
- -5.08%
- 1M
- 20.53%
- YTD
- -37.78%
- 6M
- -46.67%
- 1Y
- 7.69%
- 3Y*
- -17.44%
- 5Y*
- -35.53%
- 10Y*
- —
ENTA
- 1D
- -1.86%
- 1M
- -27.84%
- YTD
- -29.80%
- 6M
- -21.93%
- 1Y
- 48.19%
- 3Y*
- -24.76%
- 5Y*
- -25.36%
- 10Y*
- -7.18%
SES vs. ENTA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
SES SES AI Corp | -37.78% | -17.81% | 19.67% | -41.90% | -68.34% | -7.44% |
ENTA Enanta Pharmaceuticals, Inc. | -29.80% | 174.26% | -38.89% | -79.77% | -37.79% | 50.37% |
Correlation
The correlation between SES and ENTA is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Mar 2, 2021 | 0.16 |
Fundamentals
SES:
$372.78M
ENTA:
$319.83M
SES:
-$0.22
ENTA:
-$2.67
SES:
16.95
ENTA:
3.72
SES:
1.83
ENTA:
2.77
SES:
$21.92M
ENTA:
$69.21M
SES:
$7.97M
ENTA:
$33.44M
SES:
-$68.11M
ENTA:
-$61.85M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SES vs. ENTA — Risk / Return Rank
SES
ENTA
SES vs. ENTA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SES AI Corp (SES) and Enanta Pharmaceuticals, Inc. (ENTA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SES | ENTA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.37 | ||
| Sortino ratioReturn per unit of downside risk | -0.97 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.24 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 0.10 | 1.41 | -1.31 |
| Martin ratioReturn relative to average drawdown | 0.17 | 2.72 | -2.55 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SES | ENTA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.07 | 0.44 | -0.37 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.31 | -0.35 | +0.04 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.12 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.31 | -0.05 | -0.26 |
Drawdowns
SES vs. ENTA - Drawdown Comparison
The maximum SES drawdown since its inception was -97.58%, roughly equal to the maximum ENTA drawdown of -96.63%. Use the drawdown chart below to compare losses from any high point for SES and ENTA.
Loading charts...
Drawdown Indicators
| SES | ENTA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.58% | -96.63% | -0.95% |
Max Drawdown (1Y)Largest decline over 1 year | -74.08% | -34.30% | -39.78% |
Max Drawdown (3Y)Largest decline over 3 years | -91.41% | -83.61% | -7.80% |
Max Drawdown (5Y)Largest decline over 5 years | -97.58% | -95.62% | -1.96% |
Max Drawdown (10Y)Largest decline over 10 years | — | -96.63% | — |
Current DrawdownCurrent decline from peak | -89.95% | -91.24% | +1.29% |
Average DrawdownAverage peak-to-trough decline | -65.74% | -49.23% | -16.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.55% | 17.76% | +26.79% |
Volatility
SES vs. ENTA - Volatility Comparison
SES AI Corp (SES) has a higher volatility of 27.91% compared to Enanta Pharmaceuticals, Inc. (ENTA) at 13.36%. This indicates that SES's price experiences larger fluctuations and is considered to be riskier than ENTA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SES | ENTA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.91% | 13.36% | +14.55% |
Volatility (6M)Calculated over the trailing 6-month period | 76.82% | 35.53% | +41.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 107.24% | 109.93% | -2.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 114.56% | 73.36% | +41.20% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 111.60% | 60.70% | +50.90% |
Dividends
SES vs. ENTA - Dividend Comparison
Neither SES nor ENTA has paid dividends to shareholders.
Financials
SES vs. ENTA - Financials Comparison
This section allows you to compare key financial metrics between SES AI Corp and Enanta Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SES and ENTA have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SES has higher volatility (27.91%) compared to ENTA (13.36%). In terms of maximum drawdown, SES dropped -97.58% vs ENTA's -96.63%.
ENTA currently has the higher Sharpe Ratio (0.44 vs 0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SES and ENTA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer